Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform

Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a ...
Yahoo Finance

Vector Science and Therapeutics Announces Listing on the TSX Venture Exchange

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to ...
Newswire

Vector Science & Therapeutics Appoints Tabitha Hendren as Director, Engineering and Design

LODI, Wis., Oct. 2, 2025 /CNW/ -- Vector Science & Therapeutics today announced the appointment of Tabitha Hendren as Director, Engineering and Design. Hendren will report to Chief Technology Officer ...

Gary Payton II joins multi-bagger drug technology company

Vector Science & Therapeutics (TSXV:PAIN) appointed NBA Champion Gary Payton II, currently a guard for the Golden State ...
FinanzNachrichten.de

Vector Sciences & Therapeutics: Vector Science & Therapeutics Files Provisional Patent for Breakthrough Transdermal Peptide Delivery Platform

Proprietary Magnetic Patch System Delivers Regenerative Peptides to Targeted Tissue Without Injection, with Built-In Confirmation of Successful Delivery MEQUON, Wis., June 30, 2026 /PRNewswire/ -- ...